Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 1 of 147 PageID #: 2514
`Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 1of147 PagelD #: 2514
`
`
`
`
` APPENDIX D
`APPENDIX D
`
`

`

`Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 2 of 147 PageID #: 2515
`Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 2 of 147 PagelD #: 2515
`
`APPENDIX D.1
`APPENDIX D.1
`
`

`

`
`
`Case MDL No. 3103 Document 15 Filed 01/26/24 Page 1 of 1Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 3 of 147 PageID #: 2516
`
`

`

`Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 4 of 147 PageID #: 2517
`Case 1:24-cGa883@DLAKOo. BHOGMAdcibréntFied 057BAdLa1/Pagd 4RAga7 éfalgelD #: 2517
`
`EXHIBIT A
`
`The undersigned counsel for Samsung Bioepis Co., Ltd. certifies that this party is a non-
`
`governmental corporate party andthat:
`
`1.
`
`Samsung Bioepis Co., Ltd. is a wholly-ownedsubsidiary of Samsung Biologics
`
`Co., Ltd, a publicly held company.
`
`Des
`
`Samsung C&T Corporation and Samsung Electronics Co., Ltd. both publicly held
`
`companies, each own 10% or more of Samsung Biologics Co., Ltd.
`
`3.
`
`4.
`
`No publicly held company owns more than 10% of Samsung C&T Corporation.
`
`No publicly held company owns more than 10% of Samsung Electronics Co., Ltd.
`
`

`

`Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 5 of 147 PageID #: 2518
`Case 1:24-cGA@8@3@DLIKO. BHOBMAdciBréntFiee 057/BAd2a1/Pagd SRAGAZ GfayelD #: 2518
`
`BEFORE THE UNITED STATES JUDICIAL PANEL
`
`ON MULTIDISTRICT LITIGATION
`
`
`In re Aflibercept Patent Litigation
`
`
`MDLNo. 3103
`
`PROOF OF SERVICE
`
`In compliance with Rule 4.1(a) of the Rules of Procedure for the United States Judicial
`
`Panel on Multidistrict Litigation, I hereby certify that copies of the foregoing Corporate
`
`Disclosure Statement were served on all parties in the following cases electronically via ECF, or
`
`as indicated below,on this 26" day of January 2024.
`
`Counselfor Parties (Served via Email
`
`Counsel for Plaintiffs Regeneron Pharmaceuticals, Inc.
`Elizabeth S. Weiswasser
`DavidI. Berl
`Anish R.Desai
`Ellen E. Oberwetter
`Natalie C. Kennedy
`ThomasS. Fletcher
`Andrew V. Trask
`Tom Yu
`Yi Zhang
`Teagan J. Gregory
`Kathryn Leicht
`Shaun P. Mahaffy
`Kathryn S. Kayali
`Rocco Recce
`Arthur J. Argall II
`Zhen Lin
`Kellie Van Beck
`Adam Pan
`Rebecca A. Carter
`WEIL, GOTSHAL & MANGES LLP
`Haylee N. Bernal Anderson
`767 5th Avenue
`New York, NY 10153
`Renee M. Griffin
`Jennalee Beazley
`(212) 310-8000
`elizabeth.weiswasser@weil.com
`WILLIAMS & CONNOLLY LLP
`anish.desai@weil.com
`680 Maine Avenue, SW
`natalie.kennedy@weil.com
`Washington, DC 20024
`tom.yu@weil.com
`Te.l: (202) 434-5000
`yi.zhang@weil.com
`Fax: (202) 434-5029
`dberl@we.com
`kathryn.leicht@weil.com
`eoberwetter@we.com
`rocco.recce@weil.com
`tfletcher@we.com
`zhen.lin@weil.com
`kellie.vanbeck@weil.com
`atrask@we.com
`tgregory@wc.com
`smahaffy@we.com
`kkayali@we.com
`aargall@we.com
`
`Christopher M. Pepe
`Priyata Patel
`Matthew D. Sieger
`
`

`

`Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 6 of 147 PageID #: 2519
`Case 1:24-cGa883@DLSKOo. BHOBMBAdciBnéntFliee 057/BadRa1/Pagd 6RAga2 GfayelD #: 2519
`
`apan@we.com
`rebeccacarter@wc.com
`handerson@we.com
`reriffin@we.com
`jbeazley@wc.com
`
`WEIL, GOTSHAL & MANGES LLP
`2001 M Street, NW
`Suite 600
`Washington, DC 20036
`christopher.pepe@weil.com
`priyata.patel@weil.com
`matthew.sieger@weil.com
`
`Andrew E. Goldsmith
`Jacob E. Hartman
`Evan T. Leo
`Mary Charlotte Y. Carroll
`Sven E. Henningson
`KELLOGG, HANSEN, TODD, FIGEL, &
`FREDERICK, P.L.L.C.
`1615 M Street, NW, Suite 400
`Washington, DC 20036
`(202) 326-7900
`agoldsmith@kellogghansen.com
`jhartman@kellogghansen.com
`eleo@kellogghansen.com
`mearroll@kellogghansen.com
`shenningson@kellogghansen.com
`
`Steven R. Ruby
`David R. Pogue
`RaymondS. FranksII
`CAREY DOUGLAS KESSLER & RUBY, PLLC
`707 Virginia Street East
`901 Chase Tower(25301)
`P.O. Box 913
`Charleston, West Virginia 253232
`(304) 345-1234
`sruby@cdkrlaw.com
`drpogue@cdkrlaw.com
`rfranks@cdkrlaw.com
`
`Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.,
`N.D.W.Va., C.A. No. 1:22-cv-00061-TSK-JPM
`
`Counsel for Defendants/Counter-Claimants Mylan Pharmaceuticals Inc. and Biocon
`Biologics Inc.
`Abraham J. Varon
`Deanne M. Mazzochi
`Eric R. Hunt
`Heinz J. Salmen
`Jake R. Ritthamel
`
`

`

`Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 7 of 147 PageID #: 2520
`Case 1:24-cGa8®83@DLSKOo. BoOGMAdciBnéntFliee 057/BadRa1/Pagd 7 Raga. GfayelD #: 2520
`
`Jeffery A. Marx
`Katie A. Boda
`Lauren M. Lesko
`Lawrence Scott Beall
`Neil B. McLaughlin
`Steven J. Birkos
`ThomasH. Ehrich
`William A. Rakoczy
`RAKOCZY, MOLINO, MAZZOCHI & SIWIK, LLP
`6 W. HubbardSt.
`Suite 500
`Chicago, IL 60654
`avaron@rmmslegal.com
`dmazzochi@rmmslegal.com
`ehunt@rmmslegal.com
`hsalmen@rmmslegal.com
`jritthamel@rmmslegal.com
`jmarx@rmmslegal.com
`kboda@rmmslegal.com
`llesko@rmmslegal.com
`sbeall@rmmslegal.com
`nmclaughlin@rmmslegal.com
`sbirkos@rmmslegal.com
`tehrich@rmmslegal.com
`wrakoczy@rmmslegal.com
`
`Garrett Matthew Spiker
`Gordon H. Copland
`John D. Pizzo
`William J O'Brien
`Stephenee Raychel Gandee
`STEPTOE & JOHNSON PLLC
`400 White Oaks Blvd.
`Bridgeport, WV 26330
`garrett.spiker@steptoe-johnson.com
`Gordon.Copland@steptoe-johnson.com
`john.pizzo@steptoe-johnson.com
`William.Obrien@Steptoe-Johnson.com
`stephenee.gandee@steptoe-johnson.com
`
`Counsel for Intervenor Amgen USA,Inc.
`John H. Tinney, Jr.
`HENDRICKSON & LONG, PLLC
`214 Capitol Street
`P.O. Box 11070
`Charleston, WV 25301
`jtinney@handl.com
`
`

`

`Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 8 of 147 PageID #: 2521
`Case 1:24-cGa8®3@DLSKOo. BHOGMBAdciBnéntFiee 05/Badka1/Pagd Skaga4 GfayelD #: 2521
`
`Counsel for Intervenor Celltrion, Inc.
`Laura C. Davis
`MANCHIN FERRETTI, PLLC
`408 WestKing Street
`Martinsburg, WV 25401
`Idavis@wvjusticelawyers.com
`
`Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc.,
`N.D.W.Va., C.A. No. 1:23-cv-00089-TSK
`
`Counsel for Defendant Celltrion, Inc.
`Andrew C. Robey
`Carl Winfield Shaffer
`MaxC. Gottlieb
`Michael B. Hissam
`HISSAM FORMAN DONOVANRITCHIE PLLC
`707 Virginia Street, East, Suite 260
`Post Office Box 3983
`Charleston, WV 25301
`arobey@hfdrlaw.com
`cshaffer@hfdrlaw.com
`mgottlieb@hfdrlaw.com
`mhissam@hfdrlaw.com
`
`Robert Cerwinski
`Cindy Chang
`Michael Cottler
`Lora Green
`David Kim
`Brigid Morris
`Aviv Zalcenstein
`Gemini Law LLP
`40W. 24th Street
`Suite 6N
`New York, NY 10010
`rcerwinski@geminilaw.com
`cchang@geminilaw.com
`mcottler@geminilaw.com
`Igreen@geminilaw.com
`dkim@geminilaw.com
`bmorris@geminilaw.com
`azalcenstein@geminilaw.com
`
`Regeneron Pharmaceuticals, Inc. v. Formycon AG.,
`N.D.W.Va., C.A. No. 1:23-ev-00097-TSK
`
`Counsel for Defendant Formycon AG
`Bryant J. Spann
`
`

`

`Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 9 of 147 PageID #: 2522
`Case 1:24-cGA883@DLIKO. BHOGMAdclbnéntFiee 057/Badka1/Pagd 9RAGES GfayelD #: 2522
`
`M.David Griffith, Jr.
`THOMAS COMBS & SPANN, PLLC
`300 SummersStreet, Suite 1380
`P.O. Box 3824
`Charleston, WV 25338-3824
`bspann@tcspllc.com
`dgriffith@tcsplle.com
`
`Louis E. Fogel
`Shaun M. Van Horn
`Terri L. Mascherin
`
`JENNER & BLOCK LLP - CHICAGO
`353 North Clark Street
`Chicago, IL 60654
`Ifogel@jenner.com
`SVanHorn@jenner.com
`tmascherin@jenner.com
`
`Regeneron Pharmaceuticals, Inc. v. Amgen Inc.,
`C.D. Cal., C.A. No. 2:24-cv-00264
`
`Defendant AmgenInc.
`Siegmund Y. Gutman
`Shawn Scott Ledingham,Jr.
`PROSKAUER ROSE LLP
`2029 Century Park E
`Suite 2400
`Los Angeles, CA 90067-3010
`sgutman@proskauer.com
`sledingham@proskauer.com
`
`

`

`Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 10 of 147 PageID #: 2523
`Case 1:24-cVG@G@5SHT'IS NoDRIBndiodiGade nF 16d05Rlb241266241Paigh¢ oP&gelD #: 2523
`
`Dated: January 26, 2024
`
`Sandra K. Law
`SCHRADER COMPANION, DUFF & LAW, PLLC
`401 Main Street
`Wheeling, West Virginia, 26003
`
`Frank E. Simmerman,Jr.
`Chad L. Taylor
`Frank E. Simmerman,III
`SIMMERMANLAW OFFICE, PLLC
`254 East Main Street
`Clarksburg, West Virginia 26301
`(304) 623-4900
`
`QUINN EMANUEL URQUHART & SULLIVAN,
`LLP
`
`/s/ Matthew A. Traupman
`
`
`Matthew A. Traupman
`Raymond N. Nimrod
`Matthew D. Robson
`Laura L. Fairneny
`51 Madison Avenue, 22" Floor
`New York, NY 10010
`(212) 849-7000
`matthewtraupman@quinnemanuel.com
`
`Zachariah B. Summers
`865 S. FigueroaSt.
`Los Angeles, CA 90017
`(213) 443-3000
`
`Attorneys for Defendant Samsung Bioepis
`Co., Ltd.
`
`

`

`Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 11 of 147 PageID #: 2524
`Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 11 of 147 PagelD #: 2524
`
`APPENDIX D.2
`APPENDIX D.2
`
`

`

`Case MDL No. 3103 Document 16 Filed 01/26/24 Page 1 of 1Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 12 of 147 PageID #: 2525
`
`UNITED STATES JUDICIAL PANEL ON MULTIDISTRICT LITIGATION
`
`MDL No. _____________ & TITLE - IN RE: __________________________________
`
`Case Caption (Include Plaintiff, District, and Civil Action No.) (attach list if necessary):
`
`_________________________________________________________________
`
`CORPORATE DISCLOSURE STATEMENT
`
`The undersigned counsel for ___________________________, (attach list if necessary) certifies that this
`party is a non-governmental corporate party and that:
`
`This party's parent corporation(s) are listed below:
`
`The following publicly-held corporation(s) own 10% or more of the party's stock (attach list if
`necessary):
`
`OR
`
`This party does not have any parent corporations; and no publicly-held corporation owns 10% or
`more of the party's stock.
`
`_____________________________ __________________________________
` Signature of Attorney
` Name of Firm
`
`___________________________ ___________________________________
` Address
` City/State/Zip Code
`
`Date _____________________
`
`Instructions:
`
`1. Download the form. Fill out the form and save as a PDF document. All documents filed with the Judicial Panel should be in PDF Format including attachments and
`exhibits. The Corporate Disclosure Statement is to be filed as a separate document. Any documents submitted with the Corporate Disclosure Statement are attachments.
`2. Select MDL from the menu bar at the top of the ECF screen.
`3. Click on Corporate Disclosure Statement. Select Next.
`4. Enter the three or four digit number (without the MDL letters) and click the Find This Case button.
`5. If this is the correct MDL No., select next. Also, select next for the following screen.
`6. Choose the cases for which the Disclosure Statement is being filed.
`7. Select the party filing the Disclosure Statement
`8. Select the document to which the Corporate Disclosure relates. (Note: Disclosures filed in new litigations will be linked to the initial Motion for Transfer and Disclosures
`filed in transferred litigations should be linked to the Conditional Transfer Order (CTO) or Motion and Brief to Vacate CTO).
`9. Upload the Corporate Disclosure Form and any attachments as a PDF document.
`10. Submit the Disclosure Statement by selecting the Next button.
`
`3103
`
`Aflibercept Patent Litigation
`
`Regeneron Pharms. Inc. v. Celltrion, Inc. WVN/1:23-cv-00089
`
`Celltrion, Inc.
`
`4
`
`4
`
`Celltrion Inc. has no parent corporation.
`
`The entities that own 10% or more stock of Celltrion, Inc. include Celltrion Holdings, Co.
`
`/s/ Robert Cerwinski
`
`Gemini Law LLP
`
`40 W. 24th St., Suite 6N
`
`New York, NY 10010
`
`1/26/24
`
`

`

`
`Case MDL No. 3103 Document 16-1 Filed 01/26/24 Page 1 of 8Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 13 of 147 PageID #: 2526
`
`
`
`BEFORE THE UNITED STATES JUDICIAL PANEL
`ON MULTIDISTRICT LITIGATION
`
`
`
`
`In re Aflibercept Patent Litigation
`
`MDL No. 3103
`
`
`
`
`
`PROOF OF SERVICE
`
`In compliance with Rule 4.1(a) of the Rules of Procedure for the United States Judicial Panel
`
`on Multidistrict Litigation, the undersigned counsel hereby certifies that on the 26th day of January,
`
`2024, the Corporate Disclosure and Notice of Appearance were served upon all parties of record
`
`via email as reflected below:
`
`
`
`
`
`Regeneron Pharmaceuticals, Inc. v. Amgen Inc.,
`C.D. Cal., C.A. No. 2:24-cv-00264-JWH-E
`
`Counsel for Defendant Amgen Inc.
`Shawn Scott Ledingham, Jr.
`Siegmund Y Gutman
`Proskauer Rose LLP
`2029 Century Park East Suite 2400
`Los Angeles, CA 90067-3010
`sledingham@proskauer.com
`sgutman@proskauer.com
`
`Regeneron Pharmaceuticals, Inc., v. Mylan Pharmaceuticals Inc.,
`N.D. W. Va., C.A. No. 1:22-cv-00061-TSK-JPM
`
`Counsel for Defendants/Counter Claimants Mylan Pharmaceuticals Inc. and Biocon
`Biologics Inc.
`Abraham J. Varon
`Deanne M. Mazzochi
`Eric R. Hunt
`Heinz J. Salmen
`Jake R. Ritthamel
`Jeffery A. Marx
`Katie A. Boda
`Lauren M. Lesko
`
`

`

`
`
`
`Case MDL No. 3103 Document 16-1 Filed 01/26/24 Page 2 of 8Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 14 of 147 PageID #: 2527
`
`Lawrence Scott Beall
`Neil B. McLaughlin
`Steven J. Birkos
`Thomas H. Ehrich
`William A. Rakoczy
`RAKOCZY, MOLINO, MAZZOCHI & SIWIK, LLP
`6 W. Hubbard St.
`Suite 500
`Chicago, IL 60654
`avaron@rmmslegal.com
`dmazzochi@rmmslegal.com
`ehunt@rmmslegal.com
`hsalmen@rmmslegal.com
`jritthamel@rmmslegal.com
`jmarx@rmmslegal.com
`kboda@rmmslegal.com
`llesko@rmmslegal.com
`sbeall@rmmslegal.com
`nmclaughlin@rmmslegal.com
`sbirkos@rmmslegal.com
`tehrich@rmmslegal.com
`wrakoczy@rmmslegal.com
`
`Garrett Matthew Spiker
`Gordon H. Copland
`John D. Pizzo
`William J O'Brien
`Stephenee Raychel Gandee
`STEPTOE & JOHNSON PLLC
`400 White Oaks Blvd.
`Bridgeport, WV 26330
`garrett.spiker@steptoe-johnson.com
`Gordon.Copland@steptoe-johnson.com
`john.pizzo@steptoe-johnson.com
`William.Obrien@Steptoe-Johnson.com
`stephenee.gandee@steptoe-johnson.com
`
`Counsel for Intervenor Amgen USA, Inc.
`John H. Tinney, Jr.
`HENDRICKSON & LONG, PLLC
`214 Capitol Street
`P.O. Box 11070
`Charleston, WV 25301
`jtinney@handl.com
`
`
`
`2
`
`
`
`
`
`

`

`
`Case MDL No. 3103 Document 16-1 Filed 01/26/24 Page 3 of 8Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 15 of 147 PageID #: 2528
`
`
`
`
`
`
`
`Counsel for Intervenor Celltrion, Inc.
`Laura C. Davis
`MANCHIN FERRETTI, PLLC
`408 West King Street
`Martinsburg, WV 25401
`ldavis@wvjusticelawyers.com
`
`Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc.,
`N.D. W. Va., C.A. No. 1:23-cv-00089-TSK
`
`Counsel for Plaintiff Regeneron Pharmaceuticals, Inc.
`David I. Berl
`Ellen E. Oberwetter
`Thomas S. Fletcher
`Andrew V. Trask
`Teagan J. Gregory
`Shaun P. Mahaffy
`Kathryn S. Kayali
`Arthur J. Argall III
`Adam Pan
`Rebecca A. Carter
`Haylee N. Bernal Anderson Renee M. Griffin
`Jennalee Beazley
`680 Maine Avenue, SW Washington, DC 20024
`Tel.: (202) 434-5000
`Fax: (202) 434-5029
`dberl@wc.com
`eoberwetter@wc.com
`tfletcher@wc.com
`atrask@wc.com
`tgregory@wc.com
`smahaffy@wc.com
`kkayali@wc.com
`aargall@wc.com
`apan@wc.com
`rebeccacarter@wc.com
`handerson@wc.com
`rgriffin@wc.com
`jbeazley@wc.com
`
`Elizabeth S. Weiswasser
`Anish R. Desai
`Natalie C. Kennedy
`Tom Yu
`Yi Zhang
`Kathryn Leicht
`
`
`3
`
`

`

`
`Case MDL No. 3103 Document 16-1 Filed 01/26/24 Page 4 of 8Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 16 of 147 PageID #: 2529
`
`
`
`Rocco Recce
`Zhen Lin
`Kellie Van Beck
`WEIL GOTSHAL & MANGES LLP
`767 5th Avenue
`New York, NY 10153
`(212) 310-8000
`Elizabeth.Weiswasser@weil.com
`Anish.Desai@weil.com
`Natalie.Kennedy@weil.com
`Tom.Yu@weil.com
`Yi.Zhang@weil.com
`Kathryn.Leicht@weil.com
`Rocco.Recce@weil.com
`Zhen.Lin@weil.com
`Kellie.VanBeck@weil.com
`
`Christopher M. Pepe
`Priyata Y. Patel
`Matthew Sieger
`WEIL GOTSHAL & MANGES LLP
`2001 M Street NW, Suite 600
`Washington, DC 20036
`(202) 682-7000
`Christopher.Pepe@weil.com
`Priyata.Patel@weil.com
`Matthew.Seiger@weil.com
`
`
`Andrew E. Goldsmith
`Jacob E. Hartman
`Evan T. Leo
`Mary Charlotte Y. Carroll
`Sven E. Henningson
`KELLOGG, HANSEN, TODD,
`FIGEL & FREDERICK,
`P.L.L.C.
`1615 M Street, NW, Suite 400
`Washington, DC 20036
`(202) 326-7900
`agoldsmith@kellogghansen.com
`eleo@kellogghansen.com
`jhartman@kellogghansen.com
`mcarroll@kellogghansen.com
`shenningson@kellogghansen.com
`
`Steven R. Ruby
`
`
`
`4
`
`

`

`
`Case MDL No. 3103 Document 16-1 Filed 01/26/24 Page 5 of 8Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 17 of 147 PageID #: 2530
`
`
`
`
`
`
`
`
`
`
`
`
`
`David R. Pogue
`Raymond S. Franks II
`Carey Douglas Kessler & Ruby, PLLC
`707 Virginia Street East 901 Chase Tower (25301)
`P.O. Box 913
`Charleston, West Virginia 25353
`(304) 345-1234
`sruby@cdkrlaw.com
`drpogue@cdkrlaw.com
`rfranks@cdkrlaw.com
`
`Tony Bisconti
`Bienert Katzman Littrell Williams LLP
`903 Calle Amanecer, Suite 350,
`San Clemente, CA 92673 (949) 369-3700
`tbisconti@bklwlaw.com
`
`Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis Co. Ltd.,
`N.D. W. Va., C.A. No. 1:23-cv-00094-TSK
`
`Counsel for Defendant Samsung Bioepis Co. Ltd.
`Sandra K. Law
`SCHRADER COMPANION DUFF & LAW, PLLC
`401 Main Street
`Wheeling, WV 26003
`skl@schraderlaw.com
`
`Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis Co. Ltd.,
`N.D. W. Va., C.A. No. 1:23-cv-00106-TSK
`
`Counsel for Defendant Samsung Bioepis Co. Ltd.
`Chad L. Taylor
`Frank E. Simmerman, Jr.
`Frank Edward Simmerman, III
`SIMMERMAN LAW OFFICE PLLC
`254 E Main St.
`Clarksburg, WV 26301
`clt@simmermanlaw.com
`fes@simmermanlaw.com
`trey@simmermanlaw.com
`
`Laura L. Fairneny
`Matthew A. Traupman
`Raymond N. Nimrod
`QUINN EMANUEL URQUHART & SULLIVAN, LLP
`
`
`
`5
`
`

`

`
`Case MDL No. 3103 Document 16-1 Filed 01/26/24 Page 6 of 8Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 18 of 147 PageID #: 2531
`
`
`
`51 Madison Avenue
`22nd Floor
`New York, NY 10010
`laurafairneny@quinnemanuel.com
`matthewtraupman@quinnemanuel.com
`raynimrod@quinnemanuel.com
`
`Sandra K. Law
`SCHRADER COMPANION DUFF & LAW, PLLC
`401 Main Street
`Wheeling, WV 26003
`skl@schraderlaw.com
`
`Zachariah B. Summers
`QUINN EMANUEL URQUHART & SULLIVAN, LLP - LA
`865 S. Figueroa Street, 10th Floor
`Los Angeles, CA 90017
`zachsummers@quinnemanuel.com
`
`Regeneron Pharmaceuticals, Inc. v. Formycon AG,
`N.D. W. Va., C.A. No. 1:23-cv-00097-TSK
`
`Counsel for Defendant Formycon AG
`Bryant J. Spann
`M. David Griffith, Jr.
`THOMAS COMBS & SPANN, PLLC
`300 Summers Street, Suite 1380
`P.O. Box 3824
`Charleston, WV 25338-3824
`bspann@tcspllc.com
`dgriffith@tcspllc.com
`
`Louis E. Fogel
`Shaun M. Van Horn
`Terri L. Mascherin
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`6
`
`

`

`
`
`Case MDL No. 3103 Document 16-1 Filed 01/26/24 Page 7 of 8Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 19 of 147 PageID #: 2532
`
`
`JENNER & BLOCK LLP - CHICAGO
`353 North Clark Street
`Chicago, IL 60654
`lfogel@jenner.com
`SVanHorn@jenner.com
`tmascherin@jenner.com
`
`
`
`DATE: January 26, 2024
`
`
`
`
`
`
`
`/s/ Max C. Gottlieb
`Michael B. Hissam
`Max C. Gottlieb
`Andrew C. Robey
`Carl W. Shaffer
`Hissam Forman Donovan Ritchie PLLC
`P.O. Box 3983
`Charleston, WV 25339
`681-265-3802 office
`304-982-8056 fax
`mhissam@hfdrlaw.com
`mgottlieb@hfdrlaw.com
`arobey@hfdrlaw.com
`cshaffer@hfdrlaw.com
`
`Robert Cerwinski
`Aviv Zalcenstein
`Michael Cottler
`Lora Green
`David Kim
`Brigid Morris
`GEMINI LAW LLP
`40 W 24th Street
`New York, NY 10010
`(917) 915-8832
`
`Michael W. Johnson
`Matthew Freimuth
`Dan Constantinescu
`Ocean Lu
`WILLKIE FARR & GALLAGHER LLP
`787 Seventh Avenue
`
`
`
`
`
`
`
`1
`
`

`

`
`
`Case MDL No. 3103 Document 16-1 Filed 01/26/24 Page 8 of 8Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 20 of 147 PageID #: 2533
`
`
`New York, NY 10019
`(212) 728-8000
`
`
`Attorneys for Celltrion, Inc.
`
`
`
`2
`
`
`
`
`
`
`
`
`
`

`

`Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 21 of 147 PageID #: 2534
`Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 21 of 147 PagelD #: 2534
`
`APPENDIX D.3
`APPENDIX D.3
`
`

`

`Case MDL No. 3103 Document 21 Filed 01/26/24 Page 1 of 1Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 22 of 147 PageID #: 2535
`
`UNITED STATES JUDICIAL PANEL ON MULTIDISTRICT LITIGATION
`
`MDL No. _____________ & TITLE - IN RE: __________________________________
`
`Case Caption (Include Plaintiff, District, and Civil Action No.) (attach list if necessary):
`
`_________________________________________________________________
`
`CORPORATE DISCLOSURE STATEMENT
`
`The undersigned counsel for ___________________________, (attach list if necessary) certifies that this
`party is a non-governmental corporate party and that:
`
`This party's parent corporation(s) are listed below:
`
`The following publicly-held corporation(s) own 10% or more of the party's stock (attach list if
`necessary):
`
`OR
`
`This party does not have any parent corporations; and no publicly-held corporation owns 10% or
`more of the party's stock.
`
`_____________________________ __________________________________
` Signature of Attorney
` Name of Firm
`
`___________________________ ___________________________________
` Address
` City/State/Zip Code
`
`Date _____________________
`
`Instructions:
`
`1. Download the form. Fill out the form and save as a PDF document. All documents filed with the Judicial Panel should be in PDF Format including attachments and
`exhibits. The Corporate Disclosure Statement is to be filed as a separate document. Any documents submitted with the Corporate Disclosure Statement are attachments.
`2. Select MDL from the menu bar at the top of the ECF screen.
`3. Click on Corporate Disclosure Statement. Select Next.
`4. Enter the three or four digit number (without the MDL letters) and click the Find This Case button.
`5. If this is the correct MDL No., select next. Also, select next for the following screen.
`6. Choose the cases for which the Disclosure Statement is being filed.
`7. Select the party filing the Disclosure Statement
`8. Select the document to which the Corporate Disclosure relates. (Note: Disclosures filed in new litigations will be linked to the initial Motion for Transfer and Disclosures
`filed in transferred litigations should be linked to the Conditional Transfer Order (CTO) or Motion and Brief to Vacate CTO).
`9. Upload the Corporate Disclosure Form and any attachments as a PDF document.
`10. Submit the Disclosure Statement by selecting the Next button.
`
`3103
`
`Aflibercept Patent Litigation
`
`Regeneron Pharmaceuticals, Inc. v. Formycon AG, No. 1:23-cv-00097-TSK (N.D.W. Va.)
`
`Formycon AG
`
`4
`
`/s/ Terri L. Mascherin
`
`Jenner & Block LLP
`
`353 North Clark Street
`
`Chicago, IL 60654-3456
`
`1/26/2024
`
`

`

`
`
`Case MDL No. 3103 Document 21-1 Filed 01/26/24 Page 1 of 7Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 23 of 147 PageID #: 2536
`
`
`
`BEFORE THE UNITED STATES JUDICIAL PANEL
` ON MULTIDISTRICT LITIGATION
`
`
`In re Aflibercept Patent Litigation
`
`MDL No. 3103
`
`
`
`PROOF OF SERVICE
`
`In compliance with Rule 4.1(a) of the Rules of Procedure for the United States Judicial
`
`Panel on Multidistrict Litigation, I hereby certify that copies of the foregoing Corporate Disclosure
`
`Statement and this Proof of Service were served by electronic mail on January 26, 2024 to the
`
`following:
`
`COUNSEL FOR REGENERON PHARMACEUTICALS, INC.
`
`
`Regeneron Pharmaceuticals, Inc., v. Mylan
`Pharmaceuticals Inc., N.D. W. Va., C.A. No.
`1:22-cv-00061
`
`Regeneron Pharmaceuticals, Inc. v. Celltrion,
`Inc., N.D. W. Va., C.A. No. 1:23-cv-00089
`
`Regeneron Pharmaceuticals, Inc. v. Samsung
`Bioepis Co. Ltd., N.D. W. Va., C.A. No. 1:23-
`cv-00094
`
`Regeneron Pharmaceuticals, Inc. v.
`Formycon AG, N.D. W. Va., C.A. No. 1:23-
`cv-00097
`
`Regeneron Pharmaceuticals, Inc. v. Samsung
`Bioepis Co. Ltd., N.D. W. Va., C.A. No. 1:23-
`cv-00106
`
`Regeneron Pharmaceuticals, Inc. v. Amgen
`Inc., C.D. Cal., C.A. No. 2:24-cv-00264
`
`
`David I. Berl
`Ellen E. Oberwetter
`Thomas S. Fletcher
`Andrew V. Trask
`Teagan J. Gregory
`Shaun P. Mahaffy
`Kathryn S. Kayali
`Arthur J. Argall, III
`Adam Pan
`Rebecca A. Carter
`Haylee Bernal Anderson
`Renee M. Griffin
`Jennalee Beazley
`Rhochelle Krawetz
`Sean M. Douglass
`Nicholas Jordan
`WILLIAMS & CONNOLLY LLP
`680 Maine Avenue, S.W.
`Washington, DC 20024
`dberl@wc.com
`eoberwetter@wc.com
`tfletcher@wc.com
`atrask@wc.com
`tgregory@wc.com
`smahaffy@wc.com
`kkayali@wc.com
`aargall@wc.com
`
`
`
`

`

`
`
`Case MDL No. 3103 Document 21-1 Filed 01/26/24 Page 2 of 7Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 24 of 147 PageID #: 2537
`
`Regeneron Pharmaceuticals, Inc., v. Mylan
`Pharmaceuticals Inc., N.D. W. Va., C.A. No.
`1:22-cv-00061
`
`Regeneron Pharmaceuticals, Inc. v. Celltrion,
`Inc., N.D. W. Va., C.A. No. 1:23-cv-00089
`
`Regeneron Pharmaceuticals, Inc. v. Samsung
`Bioepis Co. Ltd., N.D. W. Va., C.A. No. 1:23-
`cv-00094
`
`Regeneron Pharmaceuticals, Inc. v.
`Formycon AG, N.D. W. Va., C.A. No. 1:23-
`cv-00097
`
`Regeneron Pharmaceuticals, Inc. v. Samsung
`Bioepis Co. Ltd., N.D. W. Va., C.A. No. 1:23-
`cv-00106
`
`
`apan@wc.com
`rebeccacarter@wc.com
`handerson@wc.com
`rgriffin@wc.com
`jbeazley@wc.com
`rkrawetz@wc.com
`sdouglass@wc.com
`njordan@wc.com
`
`Elizabeth S. Weiswasser
`Anish R. Desai
`Natalie C. Kennedy
`Tom Yu
`Yi Zhang
`Kathryn Leicht
`Rocco Recce
`Zhen Lin
`Kellie C. Van Beck
`Jennifer Melien Brooks Crozier
`WEIL GOTSHAL & MANGES LLP
`767 5th Avenue
`New York, NY 10153
`elizabeth.weiswasser@weil.com
`anish.desai@weil.com
`natalie.kennedy@weil.com
`tom.yu@weil.com
`yi.zhang@weil.com
`kathryn.leicht@weil.com
`rocco.recce@weil.com
`zhen.lin@weil.com
`kellie.vanbeck@weil.com
`jennifer.crozier@weil.com
`
`Christopher M. Pepe
`Priyata Y. Patel
`Matthew D. Sieger
`WEIL GOTSHAL & MANGES LLP
`2001 M Street, N.W., Suite 600
`Washington, DC 20036
`christopher.pepe@weil.com
`priyata.patel@weil.com
`matthew.seiger@weil.com
`
`Andrew E. Goldsmith
`Jacob E. Hartman
`Evan T. Leo
`
`
`
`
`
`

`

`
`
`Case MDL No. 3103 Document 21-1 Filed 01/26/24 Page 3 of 7Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 25 of 147 PageID #: 2538
`
`Mary Charlotte Y. Carroll
`Sven E. Henningson, III
`Grace W. Knofczynski
`KELLOGG, HANSEN, TODD, FIGEL &
`FREDERICK, P.L.L.C.
`1615 M Street, N.W., Suite 400
`Washington, DC 20036
`agoldsmith@kellogghansen.com
`eleo@kellogghansen.com
`jhartman@kellogghansen.com
`mcarroll@kellogghansen.com
`shenningson@kellogghansen.com
`gknofczynski@kellogghansen.com
`
`Michael W. Carey
`Steven R. Ruby
`David R. Pogue
`Raymond S. Franks, II
`S. Benjamin Bryant
`CAREY DOUGLAS KESSLER & RUBY,
`PLLC
`707 Virginia Street East
`901 Chase Tower (25301)
`P.O. Box 913
`Charleston, West Virginia 25353
`mwcarey@cdkrlawfirm.com
`sruby@cdkrlaw.com
`drpogue@cdkrlaw.com
`rfranks@cdkrlaw.com
`sbbryant@cdkrlaw.com
`
`Adam J. Bernstein
`Arunabha Bhoumik
`James Evans
`Larry Coury
`Petra Scamborova
`Regeneron Pharmaceuticals, Inc.
`777 Old Saw Mill River Road
`Tarrytown, NY 10591-6717
`adam.bernstein@regeneron.com
`arunabha.bhoumik@regeneron.com
`james.evans@regeneron.com
`larry.coury@regeneron.com
`petra.scamborova@regeneron.com
`
`Tony Bisconti
`
`
`
`
`
`Regeneron Pharmaceuticals, Inc. v. Amgen
`
`

`

`
`
`Case MDL No. 3103 Document 21-1 Filed 01/26/24 Page 4 of 7Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 26 of 147 PageID #: 2539
`
`BIENERT KATZMAN LITTRELL
`WILLIAMS LLP
`903 Calle Amanecer, Suite 350
`San Clemente, CA 92673
`tbisconti@bklwlaw.com
`
`
`Inc., C.D. Cal., C.A. No. 2:24-cv-00264
`
`
`
`
`COUNSEL FOR MYLAN PHARMACEUTICALS INC.
`AND BIOCON BIOLOGICS, INC.
`
`
`Regeneron Pharmaceuticals, Inc. v. Mylan
`Pharmaceuticals Inc., N.D. W. Va., C.A. No.
`1:22-cv-00061
`
`
`Abraham J. Varon
`Deanne M. Mazzochi
`Eric R. Hunt
`Heinz J. Salmen
`Jake R. Ritthamel
`Jeffery A. Marx
`Katie A. Boda
`Lauren M. Lesko
`Lawrence Scott Beall
`Neil B. McLaughlin
`Steven J. Birkos
`Thomas H. Ehrich
`William A. Rakoczy
`RAKOCZY, MOLINO, MAZZOCHI &
`SIWIK, LLP
`6 W. Hubbard St., Suite 500
`Chicago, IL 60654
`avaron@rmmslegal.com
`dmazzochi@rmmslegal.com
`ehunt@rmmslegal.com
`hsalmen@rmmslegal.com
`jritthamel@rmmslegal.com
`jmarx@rmmslegal.com
`kboda@rmmslegal.com
`llesko@rmmslegal.com
`sbeall@rmmslegal.com
`nmclaughlin@rmmslegal.com
`sbirkos@rmmslegal.com
`tehrich@rmmslegal.com
`wrakoczy@rmmslegal.com
`
`Garrett Matthew Spiker
`Gordon H. Copland
`John D. Pizzo
`William J O’Brien
`
`
`
`
`
`

`

`
`
`Case MDL No. 3103 Document 21-1 Filed 01/26/24 Page 5 of 7Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 27 of 147 PageID #: 2540
`
`Stephenee Raychel Gandee
`STEPTOE & JOHNSON PLLC
`400 White Oaks Blvd.
`Bridgeport, WV 26330
`garrett.spiker@steptoe-johnson.com
`gordon.copland@steptoe-johnson.com
`john.pizzo@steptoe-johnson.com
`william.obrien@steptoe-johnson.com
`stephenee.gandee@steptoe-johnson.com
`
`
`
`
`COUNSEL FOR CELLTRION, INC.
`
`
`Aviv Zalcenstein
`Lora Green
`Gemini Law LLP
`40 W. 24th Street, Suite 6N
`New York, NY 10010
`azalcenstein@geminilaw.com
`lgreen@geminilaw.com
`
`Andrew C. Robey
`Carl Winfield Shaffer
`Max C. Gottlieb
`Michael B. Hissam
`HISSAM FORMAN DONOVAN
`RITCHIE PLLC
`700 Virginia Street East, Suite 210
`P.O. Box 3983 (25339)
`Charleston, WV 25301
`arobey@hfdrlaw.com
`cshaffer@hfdrlaw.com
`mgottlieb@hfdrlaw.com
`mhissam@hfdrlaw.com
`
`Laura C. Davis
`MANCHIN FERRETTI, PLLC
`408 West King Street
`Martinsburg, WV 25401
`ldavis@wvjusticelawyers.com
`
`
`Regeneron Pharmaceuticals, Inc. v. Celltrion,
`Inc., N.D. W. Va., C.A. No. 1:23-cv-00089
`
`
`Regeneron Pharmaceuticals, Inc. v. Mylan
`Pharmaceuticals Inc., N.D. W. Va., C.A. No.
`1:22-cv-00061
`
`
`
`
`
`
`
`
`
`

`

`
`
`Case MDL No. 3103 Document 21-1 Filed 01/26/24 Page 6 of 7Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 28 of 147 PageID #: 2541
`
`COUNSEL FOR SAMSUNG BIOEPIS CO. LTD.
`
`
`Regeneron Pharmaceuticals, Inc. v. Samsung
`Bioepis Co. Ltd., N.D. W. Va., C.A. No. 1:23-
`cv-00094
`
`Regeneron Pharmaceuticals, Inc. v. Samsung
`Bioepis Co. Ltd., N.D. W. Va., C.A. No. 1:23-
`cv-00106
`
`
`Laura L. Fairneny
`Matthew D. Robson
`Matthew A. Traupman
`Raymond N. Nimrod
`QUINN EMANUEL URQUHART &
`SULLIVAN, LLP
`51 Madison Avenue
`22nd Floor
`New York, NY 10010
`laurafairneny@quinnemanuel.com
`matthewrobson@quinnemanuel.com
`matthewtraupman@quinnemanuel.com
`raynimrod@quinnemanuel.com
`
`Zachariah B. Summers
`QUINN EMANUEL URQUHART &
`SULLIVAN, LLP
`865 S. Figueroa Street, 10th Floor
`Los Angeles, CA 90017
`zachsummers@quinnemanuel.com
`
`Chad L. Taylor
`Frank E. Simmerman, Jr.
`Frank Edward Simmerman, III
`SIMMERMAN LAW OFFICE PLLC
`254 E Main St
`Clarksburg, WV 26301
`clt@simmermanlaw.com
`fes@simmermanlaw.com
`trey@simmermanlaw.com
`
`Sandra K. Law
`SCHRADER COMPANION DUFF &
`LAW, PLLC
`401 Main Street
`Wheeling, WV 26003
`skl@schraderlaw.com
`
`
`COUNSEL FOR AMGEN, INC.
`
`
`Shawn Scott Ledingham, Jr.
`Siegmund Y Gutman
`
`Regeneron Pharmaceuticals, Inc. v. Amgen
`Inc., C.D. Cal., C.A. No. 2:24-cv-00264
`
`
`
`
`
`
`
`
`

`

`
`
`Case MDL No. 3103 Document 21-1 Filed 01/26/24 Page 7 of 7Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 29 of 147 PageID #: 2542
`
`
`
`PROSKAUER ROSE LLP
`2029 Century Park East Suite 2400
`Los Angeles, CA 90067-3010
`sledingham@proskauer.com
`sgutman@proskauer.com
`
`
`
`
`
`
`
`
`
`
`
`Dated: January 26, 2024
`
`
`
`
`OF COUNSEL:
`
`
`
`
`
`
`
`
`
`Bryant J. Spann
`
`
`M. David Griffith, Jr.
`THOMAS COMBS & SPANN PLLC
`300 Summers Street, Suite 1380
`
`Charleston, West Virginia
`
`
`(304) 414-1800
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`JENNER & BLOCK LLP
`
`
`
`/s/ Terri L. Mascherin
`Terri L. Mascherin
`Louis E. Fogel
`Shaun M. Van Horn
`353 North Clark Street
`Chicago, Illinois 60654
`(312) 222-9350
`
`Attorneys for Defendant Formycon AG
`
`
`
`

`

`Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 30 of 147 PageID #: 2543
`Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 30 of 147 PagelD #: 2543
`
`APPENDIX D.4
`APPENDIX D.4
`
`

`

`
`
`Case MDL No. 3103 Document 24 Filed 02/02/24 Page 1 of 25Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 31 of 147 PageID #: 2544
`
`
`
`BEFORE THE UNITED STATES JUDICIAL PANEL
`ON MULTIDISTRICT LITIGATION
`
`
`
`
`
`MDL No. 3103
`
`
`SAMSUNG BIOEPIS CO., LTD.’S, CELLTRION, INC.’S, AND
`FORMYCON AG’S OPPOSITION TO PLAINTIFF’S MOTION TO TRANSFER
`
`In re: Aflibercept Patent Litigation
`
`
`
`
`
`

`

`
`
`Case MDL No. 3103 Document 24 Filed 02/02/24 Page 2 of 25Case 1:24-cv-00053-TSK Document 16-4 Filed 05/31/24 Page 32 of 147 PageID #: 2545
`
`
`
`TABLE OF CONTENTS
`
`I. 
`
`II. 
`
`III. 
`
`IV. 
`
`V. 
`
`Introduction ......................................................................................................................... 1 
`
`Background ......................................................................................................................... 3 
`
`Regeneron’s Motion Improperly Seeks to Circumvent the PI Defendants’ Challenge to
`Personal Jurisdiction ........................................................................................................... 4 
`
`B